Number of unique patients dispensed alectinib (Alecensa) cap 150 mg per month from 1 December 2019
Thank you for your request dated 3 March 2022 under the Official Information Act 1982 (OIA) for information relating to alectinib. You requested:
Alectinib patient numbers (month by month) since date of funding (1 December 2019)
I am pleased to provide you with the data for your request within the table at the end of this letter.
We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Table: Number of unique patients dispensed alectinib (Alecensa) cap 150 mg per month from 1 December 2019
|Month||Number of patients|
- The data contains the number of patients per month dispensed alectinib for the period from 01/12/2019 to 31/12/2021. Data from 01/01/2022 is not provided as there is a lag of approximately 6 weeks between dispensing and when data becomes available to Pharmac. Additionally, pharmacies can continue to submit claims up to 6 months after dispensing.
- The data provided represents publicly funded medicines dispensed in the community based on pharmacy claims; patients dispensed in DHB hospitals are not included in the data.
- While patient counts are valid at the level given (i.e. per year and month, per chemical, per formulation, per brand), they should not be aggregated, as this may result in double counting of some patients.